| FOR      IMMEDIATE RELEASE   |   |                     |
|------------------------------|--------|--------------------------|
|                         |   |                     |
| Company      Contacts:       |   | Investor      Relations: |
| Stephen      Ross            |   | Ron      Both            |
| Chief      Financial Officer |   | Managing      Director   |
| Remedent,      Inc.          |   | Liolios      Group, Inc. |
| Tel      310-922-5685        |   | Tel      949-574-3860    |
| stephenr@remedent.com        |   | info@liolios.com         |

----

----

----

|                                                                                                                                                  |   | June 30, 2009 |        |   | March 31, 2009 |   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------------|-------------|--------|----------------|--------|
| ASSETS                                                                                                                                                |   |          |        |   |           |   |
| CURRENT      ASSETS:                                                                                                                                  |   |          |        |   |           |   |
| Cash      and cash equivalents                                                                                                                        |   | $             | 1,598,294   |   |           | $      | 1,807,271 |   |
| Accounts      receivable, net of allowance for doubtful accounts of $36,188 at June 30,      2009 and $33,966 at March 31, 2009                       |   |          | 3,373,343   |   |           |   | 3,208,120 |   |
| Inventories,      net                                                                                                                                 |   |          | 2,056,141   |   |           |   | 1,937,946 |   |
| Prepaid      expense                                                                                                                                  |   |          | 1,321,700   |   |           |   | 1,310,900 |   |
| Total      current assets                                                                                                                             |   |          | 8,349,478   |   |           |   | 8,264,237 |   |
| PROPERTY      AND EQUIPMENT, NET                                                                                                                      |   |          | 1,001,394   |   |           |   | 1,024,999 |   |
| OTHER      ASSETS                                                                                                                                     |   |          |        |   |           |   |   |   |
| Long      term investments and advances                                                                                                               |   |          | 750,000     |   |           |   | 750,000 |   |
| Patents,      net                                                                                                                                     |   |          | 75,092      |   |           |   | 163,106 |   |
| Total      assets                                                                                                                                     |   | $             | 10,175,964  |   |           | $      | 10,202,342 |   |
|                                                                                                                                                  |   |          |        |   |           |   |   |   |
| LIABILITIES      AND STOCKHOLDERS’ EQUITY (DEFICIT)                                                                                             |   |          |        |   |           |   |   |   |
| CURRENT      LIABILITIES:                                                                                                                             |   |          |        |   |           |   |   |   |
| Current      portion, long term debt                                                                                                                  |   | $             | 59,414      |   |           | $      | 78,798 |   |
| Line      of Credit                                                                                                                                   |   |          | 1,477,140   |   |           |   | 660,200 |   |
| Accounts      payable                                                                                                                                 |   |          | 1,508,368   |   |           |   | 1,398,420 |   |
| Accrued      liabilities                                                                                                                              |   |          | 987,286     |   |           |   | 1,590,360 |   |
| Income      taxes payable                                                                                                                             |   |          | 37,107      |   |           |   | 39,339 |   |
| Total      current liabilities                                                                                                                        |   |          | 4,069,315   |   |           |   | 3,767,117 |   |
| Long      term debt less current portion                                                                                                              |   |          | 100,542     |   |           |   | 100,542 |   |
| Total      liabilities                                                                                                                                |   |          | 4,169,857   |   |           |   | 3,867,659 |   |
|                                                                                                                                                  |   |          |        |   |           |   |   |   |
| EQUITY:                                                                                                                                               |   |          |        |   |           |   |   |   |
| REMEDENT,      INC. STOCKHOLDERS’ EQUITY                                                                                                        |   |          |        |   |           |   |   |   |
| Preferred      Stock $0.001 par value (10,000,000 shares authorized, none issued and      outstanding)                                                |   |          | —     |   |           |   | — |   |
| Common      stock, $0.001 par value; (50,000,000 shares authorized, 19,995,969 shares      issued and outstanding at June 30, 2009 and March 31,2009) |   |          | 19,996      |   |           |   | 19,996 |   |
| Treasury      stock, at cost; 723,000      at June 30, 2009 and March 31, 2009                                                                        |   |          | (831,450    | )      |           |   | (831,450 | ) |
| Additional      paid-in capital                                                                                                                       |   |          | 24,207,505  |   |           |   | 24,106,055 |   |
| Accumulated      deficit                                                                                                                              |   |          | (17,765,460 | )      |           |   | (17,216,028 | ) |
| Accumulated      other comprehensive income (loss) (foreign currency translation      adjustment)                                                     |   |          | (583,027    | )      |           |   | (640,595 | ) |
| Total      Remedent, Inc. stockholders’ equity                                                                                                  |   |          | 5,047,564   |   |           |   | 5,437,978 |   |
| Non-controlling      interest                                                                                                                         |   |          | 958,543     |   |           |   | 896,705 |   |
| Total      stockholders’ equity                                                                                                                 |   |          | 6,006,107   |   |           |   | 6,334,683 |   |
| Total      liabilities and equity                                                                                                                     |   | $             | 10,175,964  |   |           | $      | 10,202,342 |   |

----

|                                                                                     |   | For      the three months ended |       |
|------------------------------------------------------------------------------------------|--------|---------------------------------|------------|
|                                                                                     |   | June      30,                   |       |
|                                                                                     |   |                            |       |
|                                                                                     |   | 2009                            |       |   | 2008 |   |
|                                                                                     |   |                            |       |   |   |   |
| Net      sales                                                                           |   | $                               | 2,160,803  |   |   | $ | 3,635,479 |   |
| Cost      of sales                                                                       |   |                            | 1,096,007  |   |   |   | 1,269,424 |   |
| Gross      profit                                                                        |   |                            | 1,064,796  |   |   |   | 2,366,055 |   |
| Operating      Expenses                                                                  |   |                            |       |   |   |   |   |   |
| Research      and development                                                            |   |                            | 26,598     |   |   |   | 124,948 |   |
| Sales      and marketing                                                                 |   |                            | 350,935    |   |   |   | 671,299 |   |
| General      and administrative                                                          |   |                            | 1,042,764  |   |   |   | 1,130,313 |   |
| Depreciation      and amortization                                                       |   |                            | 173,444    |   |   |   | 91,261 |   |
| TOTAL      OPERATING EXPENSES                                                            |   |                            | 1,593,741  |   |   |   | 2,017,831 |   |
|                                                                                     |   |                            |       |   |   |   |   |   |
| INCOME      (LOSS) FROM OPERATIONS                                                       |   |                            | (528,945   | ) |   |   | 348,224 |   |
| OTHER      INCOME (EXPENSES)                                                             |   |                            |       |   |   |   |   |   |
| Interest      expense                                                                    |   |                            | (24,647    | ) |   |   | (35,343 | ) |
| Other      income                                                                        |   |                            | 65,998     |   |   |   | 17,621 |   |
| TOTAL      OTHER INCOME (EXPENSES)                                                       |   |                            | 41,351     |   |   |   | (17,723 | ) |
|                                                                                     |   |                            |       |   |   |   |   |   |
| NET      (LOSS) INCOME                                                                   |   |                            | (487,594   | ) |   |   | 330,501 |   |
|                                                                                     |   |                            |       |   |   |   |   |   |
| LESS:      NET INCOME ATTRIBUTABLE TO THE NON-CONTROLLING INTEREST                       |   |                            | 61,838     |   |   |   | — |   |
|                                                                                     |   |                            |       |   |   |   |   |   |
| NET      (LOSS) INCOME ATTRIBUTABLE TO REMEDENT, INC. Common      Stockholders           |   | $                               | (549,432   | ) |   | $ | 330,501 |   |
|                                                                                     |   |                            |       |   |   |   |   |   |
| INCOME      (LOSS) PER SHARE                                                             |   |                            |       |   |   |   |   |   |
| Basic                                                                                    |   | $                               | (0.03      | ) |   | $ | 0.02 |   |
| Fully      diluted                                                                       |   | $                               | (0.03      | ) |   | $ | 0.01 |   |
|                                                                                     |   |                            |       |   |   |   |   |   |
| WEIGHTED      AVERAGE SHARES OUTSTANDING                                                 |   |                            |       |   |   |   |   |   |
| Basic                                                                                    |   |                            | 19,995,969 |   |   |   | 18,637,803 |   |
| Fully      diluted                                                                       |   |                            | 32,702,274 |   |   |   | 27,000,995 |   |
|                                                                                     |   |                            |       |   |   |   |   |   |
| NET      (LOSS) INCOME                                                                   |   | $                               | (487,594   | ) |   | $ | 330,501 |   |
|                                                                                     |   |                            |       |   |   |   |   |   |
| OTHER      COMPREHENSIVE INCOME (LOSS)                                                   |   |                            |       |   |   |   |   |   |
| Foreign      currency translation adjustment                                             |   |                            | 57,568     |   |   |   | 27,592 |   |
|                                                                                     |   |                            |       |   |   |   |   |   |
| TOTAL      OTHER COMPREHENSIVE (LOSS) INCOME                                             |   |                            | (491,864   | ) |   |   | 358,093 |   |
|                                                                                     |   |                            |       |   |   |   |   |   |
| LESS:      COMPREHENSIVE INCOME ATTRIBUTABLE TO NON-CONTROLLING    INTEREST              |   |                            | 42,248     |   |   |   | — |   |
|                                                                                     |   |                            |       |   |   |   |   |   |
| COMPREHENSIVE      (LOSS) INCOME ATTRIBUTABLE TO REMEDENT INC., Common      Stockholders |   | $                               | (534,112   | ) |   | $ | 358,093 |   |

----